Blocking EGFR in the liver improves the tumor-to-liver uptake ratio of radiolabeled EGF

Tumor Biology

Volumn 31, Issue 2, 2010, Pages 79-87

  Kareem, Heewa ^a   Sandström, Karl ^a   Elia, Ronny ^a   Gedda, Lars ^a   Anniko, Matti ^a   Lundqvist, Hans ^a   Nestor, Marika ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Affibody molecule; EGF; EGFR; HNSCC; Imaging; Tumor to liver ratio

Indexed keywords

EPIDERMAL GROWTH FACTOR INDIUM 111; EPIDERMAL GROWTH FACTOR IODINE 125; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; RADIOISOTOPE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER TRANSPLANTATION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DRUG DISTRIBUTION; DRUG TISSUE LEVEL; DRUG TUMOR LEVEL; FEMALE; HUMAN; HUMAN CELL; ISOTOPE LABELING; LIVER TUMOR; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING;

EID: 77951252397     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-009-0011-2     Document Type: Article

References (30)

1. L Dobrossy 2005 Epidemiology of head and neck cancer: magnitude of the problem Cancer Metastasis Rev 24 9 17 10.1007/s10555-005-5044-4 15785869 (Pubitemid 40584773)
2. A Ferlito A Rinaldo CE Silver AR Shaha 2006 The head and neck surgeon as oncologist Am J Otolaryngol 27 73 5 10.1016/j.amjoto.2005.07.022 16500466 (Pubitemid 43267269)
3. I Ganly SB Kaye 2000 Recurrent squamous-cell carcinoma of the head and neck: overview of current therapy and future prospects Ann Oncol 11 11 6 10.1023/A:1008330026617 1:STN:280:DC%2BD3c7lsV2ksw%3D%3D 10690381 (Pubitemid 30084573)
4. MM Kim JA Califano 2004 Molecular pathology of head-and-neck cancer Int J Cancer 112 545 53 10.1002/ijc.20379 1:CAS:528:DC%2BD2cXptlGjsb4%3D 15382034 (Pubitemid 39425933)
5. ML Poeta J Manola MA Goldwasser A Forastiere N Benoit JA Califano JA Ridge J Goodwin D Kenady J Saunders W Westra D Sidransky WM Koch 2007 TP53 mutations and survival in squamous-cell carcinoma of the head and neck N Engl J Med 357 2552 61 10.1056/NEJMoa073770 1:CAS:528:DC%2BD2sXhsVKht7rP 18094376 (Pubitemid 350294222)
6. Y Yarden MX Sliwkowski 2001 Untangling the ErbB signalling network Nat Rev Mol Cell Biol 2 127 37 10.1038/35052073 1:CAS:528:DC%2BD3MXivVWnt7k%3D 11252954 (Pubitemid 33674041)
7. TA Libermann HR Nusbaum N Razon R Kris I Lax H Soreq N Whittle MD Waterfield A Ullrich J Schlessinger 1985 Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin Nature 313 144 7 10.1038/313144a0 1:CAS:528:DyaL2MXhtVOgsbg%3D 2981413 (Pubitemid 15192341)
8. A Ullrich L Coussens JS Hayflick TJ Dull A Gray AW Tam J Lee Y Yarden TA Libermann J Schlessinger, et al. 1984 Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells Nature 309 418 25 10.1038/309418a0 1:CAS:528:DyaL2cXkvVCrsL0%3D 6328312 (Pubitemid 14102443)
9. N Kamata K Chida K Rikimaru M Horikoshi S Enomoto T Kuroki 1986 Growth-inhibitory effects of epidermal growth factor and overexpression of its receptors on human squamous cell carcinomas in culture Cancer Res 46 1648 53 1:CAS:528:DyaL28XhvVSks7g%3D 3004701 (Pubitemid 16121484)
10. R Mandic N Eikelkamp R Peldszus M Sadowski AM Sesterhenn AA Dunne JA Werner 2001 Variations of EGF-R surface expression in squamous cell carcinomas of the head and neck region Anticancer Res 21 3413 8 1:CAS:528: DC%2BD38XhvFGms7o%3D 11848502 (Pubitemid 34224245)
11. J Rubin Grandis MF Melhem EL Barnes DJ Tweardy 1996 Quantitative immunohistochemical analysis of transforming growth factor-alpha and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck Cancer 78 1284 92 10.1002/(SICI)1097-0142(19960915)78:6<1284::AID- CNCR17>3.0.CO;2-X 1:STN:280:DyaK28visVChuw%3D%3D 8826952 (Pubitemid 26303896)
12. CH Chung JS Parker G Karaca J Wu WK Funkhouser D Moore D Butterfoss D Xiang A Zanation X Yin WW Shockley MC Weissler LG Dressler CG Shores WG Yarbrough CM Perou 2004 Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression Cancer Cell 5 489 500 10.1016/S1535-6108(04)00112-6 1:CAS:528:DC%2BD2cXksFCmtLw%3D 15144956 (Pubitemid 38610250)
13. L Castillo MC Etienne-Grimaldi JL Fischel P Formento N Magne G Milano 2004 Pharmacological background of EGFR targeting Ann Oncol 15 1007 12 10.1093/annonc/mdh257 1:STN:280:DC%2BD2czgt1SqsQ%3D%3D 15205192 (Pubitemid 39089775)
14. V Tolmachev M Friedman M Sandstrom TL Eriksson D Rosik M Hodik S Stahl FY Frejd A Orlova 2009 Affibody molecules for epidermal growth factor receptor targeting in vivo: aspects of dimerization and labeling chemistry J Nucl Med 50 274 83 10.2967/jnumed.108.055525 19164241
15. FY Nilsson V Tolmachev 2007 Affibody molecules: new protein domains for molecular imaging and targeted tumor therapy Curr Opin Drug Discov Dev 10 167 75 1:CAS:528:DC%2BD2sXktVOntrw%3D (Pubitemid 46438646)
16. V Tolmachev A Orlova FY Nilsson J Feldwisch A Wennborg L Abrahmsen 2007 Affibody molecules: potential for in vivo imaging of molecular targets for cancer therapy Expert Opin Biol Ther 7 555 68 10.1517/14712598.7.4.555 1:CAS:528:DC%2BD2sXjt1yns78%3D 17373906 (Pubitemid 46524679)
17. CR Divgi S Welt M Kris FX Real SD Yeh R Gralla B Merchant S Schweighart M Unger SM Larson, et al. 1991 Phase I and imaging trial of indium 111-labeled anti-epidermal growth factor receptor monoclonal antibody 225 in patients with squamous cell lung carcinoma J Natl Cancer Inst 83 97 104 10.1093/jnci/83.2.97 1:STN:280:DyaK3M7gvVygug%3D%3D 1988695
18. P Bernhardt L Kolby V Johanson O Nilsson H Ahlman E Forssell-Aronsson 2003 Biodistribution of 111in-DTPA-D-Phe1-octreotide in tumor-bearing nude mice: influence of amount injected and route of administration Nucl Med Biol 30 253 60 10.1016/S0969-8051(02)00417-1 1:CAS:528:DC%2BD3sXjs1Cqu7s%3D 12745016 (Pubitemid 36556240)
19. WA Breeman DJ Kwekkeboom PP Kooij WH Bakker LJ Hofland TJ Visser GJ Ensing SW Lamberts EP Krenning 1995 Effect of dose and specific activity on tissue distribution of indium-111-pentetreotide in rats J Nucl Med 36 623 7 1:CAS:528:DyaK2MXls1KltLg%3D 7699456
20. M de Jong WA Breeman BF Bernard A van Gameren E de Bruin WH Bakker ME van der Pluijm TJ Visser HR Macke EP Krenning 1999 Tumour uptake of the radiolabelled somatostatin analogue [DOTA0, TYR3]octreotide is dependent on the peptide amount Eur J Nucl Med 26 693 8 10.1007/s002590050439 10398816 (Pubitemid 29338656)
21. EGFR:2377 affibody molecule: aspect of injected tracer amount. Eur J Nucl Med Mol Imaging 2009; doi: 10.1007/s00259-009-1283-x.
22. E Nordberg M Friedman L Gostring GP Adams H Brismar FY Nilsson S Stahl B Glimelius J Carlsson 2007 Cellular studies of binding, internalization and retention of a radiolabeled EGFR-binding affibody molecule Nucl Med Biol 34 609 18 10.1016/j.nucmedbio.2007.05.010 1:CAS:528:DC%2BD2sXpt1eitrw%3D 17707800 (Pubitemid 47248288)
23. RI Nicholson JM Gee ME Harper 2001 EGFR and cancer prognosis Eur J Cancer 37 Suppl 4 S9 15 10.1016/S0959-8049(01)00231-3 1:CAS:528:DC%2BD3MXntlOku7w%3D 11597399
24. O Dassonville JL Formento M Francoual A Ramaioli J Santini M Schneider F Demard G Milano 1993 Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer J Clin Oncol 11 1873 8 1:STN:280: DyaK2c%2FhsFajtg%3D%3D 8410112 (Pubitemid 23304610)
25. M Hu D Scollard C Chan P Chen K Vallis RM Reilly 2007 Effect of the EGFR density of breast cancer cells on nuclear importation, in vitro cytotoxicity, and tumor and normal-tissue uptake of [111In]DTPA-hEGF Nucl Med Biol 34 887 96 10.1016/j.nucmedbio.2007.06.010 1:CAS:528:DC%2BD2sXht12jtrzN 17998090 (Pubitemid 350061165)
26. L Ekerljung M Lindborg L Gedda FY Frejd J Carlsson J Lennartsson 2008 Dimeric HER2-specific affibody molecules inhibit proliferation of the SKBR-3 breast cancer cell line Biochem Biophys Res Commun 377 489 94 10.1016/j.bbrc.2008.10.027 1:CAS:528:DC%2BD1cXhtlykt7vO 18930032
27. L Ekerljung AC Steffen J Carlsson J Lennartsson 2006 Effects of HER2-binding affibody molecules on intracellular signaling pathways Tumour Biol 27 201 10 10.1159/000093023 1:CAS:528:DC%2BD28XkslWns7o%3D 16651854 (Pubitemid 43752199)
28. LB Shih SR Thorpe GL Griffiths H Diril GL Ong HJ Hansen DM Goldenberg MJ Mattes 1994 The processing and fate of antibodies and their radiolabels bound to the surface of tumor cells in vitro: a comparison of nine radiolabels J Nucl Med 35 899 908 1:CAS:528:DyaK2cXlt1yqs78%3D 8176479 (Pubitemid 24151232)
29. DA Fisher EC Salido L Barajas 1989 Epidermal growth factor and the kidney Annu Rev Physiol 51 67 80 10.1146/annurev.ph.51.030189.000435 1:CAS:528:DyaL1MXitVGrtLo%3D 2653200 (Pubitemid 19088308)
30. M Nestor T Ekberg J Dring GA van Dongen K Wester V Tolmachev M Anniko 2007 Quantification of CD44v6 and EGFR expression in head and neck squamous cell carcinomas using a single-dose radioimmunoassay Tumour Biol 28 253 63 10.1159/000110898 1:CAS:528:DC%2BD2sXhtlCgsbnI 17992053 (Pubitemid 350165831)